Literature DB >> 15017522

Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

Rajiv Agarwal1, Ruth C Campbell, David G Warnock.   

Abstract

Angiotensin II, via the type 1 (AT1) receptor, stimulates oxidative stress. The vasculature, interstitium, juxtaglomerular apparatus, and the distal nephron in the kidney express nicotinamide adenine dinucleotide phosphate (NADPH) oxidase that generates superoxide anion, which is an important component of angiotensin II-induced oxidative stress. The angiotensinogen gene is stimulated by NF-kappaB activation, which is sensitive to the redox ratio, providing a positive feedback loop that can upregulate angiotensin II production. Oxidative stress can accompany hypertension in many models, including the spontaneously hypertensive rat (SHR), angiotensin II-infused rats, renovascular hypertension, and the deoxycorticosterone acetate (DOCA) salt model of hypertension. AT1 receptor antagonists can abrogate the effects of angiotensin II on oxidative stress, thus providing an important mechanistic insight onto the renal protective effects of these agents in conditions associated with angiotensin II excess.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017522     DOI: 10.1016/j.semnephrol.2003.11.008

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  31 in total

Review 1.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

2.  Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Kristal J Aaron; Ruth C Campbell; Suzanne E Judd; Paul W Sanders; Paul Muntner
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

Review 3.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

4.  NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea.

Authors:  Guanxia Zhan; Faridis Serrano; Polina Fenik; Ray Hsu; Linghao Kong; Domenico Pratico; Eric Klann; Sigrid C Veasey
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

5.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

6.  Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.

Authors:  Yuying Liu; Grant Bledsoe; Makato Hagiwara; Zhi-Rong Yang; Bo Shen; Lee Chao; Julie Chao
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-20

Review 7.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

8.  Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4.

Authors:  Gholamreza Fazeli; Helga Stopper; Reinhard Schinzel; Chih-Wen Ni; Hanjoong Jo; Nicole Schupp
Journal:  Mutagenesis       Date:  2012-07-27       Impact factor: 3.000

9.  Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.

Authors:  F Jiang; G T Jones; G J Dusting
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

10.  Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.

Authors:  P M Snijder; A R Frenay; R A de Boer; A Pasch; J L Hillebrands; H G D Leuvenink; H van Goor
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.